Astrana Health (NASDAQ:ASTH – Free Report) had its price target raised by Robert W. Baird from $54.00 to $67.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an outperform rating on the stock.
A number of other brokerages have also issued reports on ASTH. Baird R W upgraded shares of Astrana Health to a strong-buy rating in a research note on Thursday, May 30th. Truist Financial upped their price target on Astrana Health from $50.00 to $59.00 and gave the stock a buy rating in a report on Friday, August 9th. Finally, Stifel Nicolaus increased their price target on Astrana Health from $48.00 to $60.00 and gave the company a buy rating in a research report on Thursday, August 1st. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of Buy and an average target price of $59.00.
View Our Latest Stock Report on ASTH
Astrana Health Price Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The firm had revenue of $486.30 million during the quarter, compared to the consensus estimate of $440.68 million. During the same period last year, the company earned $0.28 EPS. The company’s quarterly revenue was up 39.7% on a year-over-year basis. As a group, research analysts expect that Astrana Health will post 1.42 EPS for the current year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
- Five stocks we like better than Astrana Health
- What Investors Need to Know to Beat the Market
- This Small Cap Wealth Management Stock Could Provide Big Returns
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.